iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors

Melguizo-Sanchis, Dario; Xu, Yaobo; Taheem, Dheraj; Yu, Min; Tilgner, Katarzyna; Barta, Tomas; Gassner, Katja; Anyfantis, George; Wan, Tengfei; Elango, Ramu; Alharthi, Sameer; El-Harouni, Ashraf A.; Przyborski, Stefan; Adam, Soheir; Saretzki, Gabriele; Samarasinghe, Sujith; Armstrong, Lyle; Lako, Majlinda

Abstract

Aplastic Anemia (AA) is a bone marrow failure (BMF) disorder, resulting in bone marrow hypocellularity and peripheral pancytopenia. Severe aplastic anemia (SAA) is a subset of AA defined by a more severe phenotype. Although the immunological nature of SAA pathogenesis is widely accepted, there is an increasing recognition of the role of dysfunctional hematopoietic stem cells in the disease phenotype. While pediatric SAA can be attributable to genetic causes, evidence is evolving on previously unrecognized genetic etiologies in a proportion of adults with SAA. Thus, there is an urgent need to better understand the pathophysiology of SAA, which will help to inform the course of disease progression and treatment options. We have derived induced pluripotent stem cell (iPSC) from three unaffected controls and three SAA patients and have shown that this in vitro model mimics two key features of the disease: (1) the failure to maintain telomere length during the reprogramming process and hematopoietic differentiation resulting in SAA-iPSC and iPSC-derived-hematopoietic progenitors with shorter telomeres than controls; (2) the impaired ability of SAA-iPSC-derived hematopoietic progenitors to give rise to erythroid and myeloid cells. While apoptosis and DNA damage response to replicative stress is similar between the control and SAA-iPSC-derived-hematopoietic progenitors, the latter show impaired proliferation which was not restored by eltrombopag, a drug which has been shown to restore hematopoiesis in SAA patients. Together, our data highlight the utility of patient specific iPSC in providing a disease model for SAA and predicting patient responses to various treatment modalities.

Citation

Melguizo-Sanchis, D., Xu, Y., Taheem, D., Yu, M., Tilgner, K., Barta, T., …Lako, M. (2018). iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors. Cell Death and Disease, 9(2), Article 128. https://doi.org/10.1038/s41419-017-0141-1

• Journal Article Type: Article
• Acceptance Date: Nov 10, 2017
• Online Publication Date: Jan 26, 2018
• Publication Date: Jan 26, 2018
• Deposit Date: Feb 15, 2018
• Publicly Available Date: Feb 15, 2018
• Journal: Cell Death and Disease
• Publisher: Springer Nature
• Peer Reviewed: Peer Reviewed
• Volume: 9
• Issue: 2
• Article Number: 128
• DOI: https://doi.org/10.1038/s41419-017-0141-1
• Public URL: https://durham-repository.worktribe.com/output/1339058